Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 04 08 2023
accepted: 11 01 2024
medline: 16 2 2024
pubmed: 16 2 2024
entrez: 16 2 2024
Statut: epublish

Résumé

Gut microbiota may be involved in the presence of irritable bowel syndrome (IBS)-like symptomatology in ulcerative colitis (UC) patients in remission. Bread is an important source of dietary fiber, and a potential prebiotic. To assess the effect of a bread baked using traditional elaboration, in comparison with using modern elaboration procedures, in changing the gut microbiota and relieving IBS-like symptoms in patients with quiescent ulcerative colitis. Thirty-one UC patients in remission with IBS-like symptoms were randomly assigned to a dietary intervention with 200 g/d of either treatment or control bread for 8 weeks. Clinical symptomatology was tested using questionnaires and inflammatory parameters. Changes in fecal microbiota composition were assessed by high-throughput sequencing of the 16S rRNA gene. A decrease in IBS-like symptomatology was observed after both the treatment and control bread interventions as reductions in IBS-Symptom Severity Score values (p-value < 0.001) and presence of abdominal pain (p-value < 0.001). The treatment bread suggestively reduced the Firmicutes/Bacteroidetes ratio (p-value = 0.058). In addition, the Firmicutes/Bacteroidetes ratio seemed to be associated with improving IBS-like symptoms as suggested by a slight decrease in patient without abdominal pain (p-value = 0.059). No statistically significant differential abundances were found at any taxonomic level. The intake of a bread baked using traditional elaboration decreased the Firmicutes/Bacteroidetes ratio, which seemed to be associated with improving IBS-like symptoms in quiescent ulcerative colitis patients. These findings suggest that the traditional bread elaboration has a potential prebiotic effect improving gut health (ClinicalTrials.gov ID number of study: NCT05656391).

Identifiants

pubmed: 38363772
doi: 10.1371/journal.pone.0297836
pii: PONE-D-23-21156
doi:

Banques de données

ClinicalTrials.gov
['NCT05656391']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0297836

Informations de copyright

Copyright: © 2024 Lluansí et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Aleix Lluansí (A)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Marc Llirós (M)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Robert Carreras-Torres (R)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Anna Bahí (A)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Montserrat Capdevila (M)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Anna Feliu (A)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Laura Vilà-Quintana (L)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Núria Elias-Masiques (N)

Elias-Boulanger S.L., Vilassar de Mar, Spain.

Emilio Cueva (E)

Elias-Boulanger S.L., Vilassar de Mar, Spain.

Laia Peries (L)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Leyanira Torrealba (L)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Josep Oriol Miquel-Cusachs (JO)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Míriam Sàbat (M)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital de Santa Caterina, Girona, Spain.

David Busquets (D)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Carmen López (C)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Sílvia Delgado-Aros (S)

Gastroenterology Scientific advisor to Elias-Boulanger S.L., Vilassar de Mar, Spain.

Librado Jesús Garcia-Gil (LJ)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.
Department of Biology, Universitat de Girona, Girona, Spain.

Isidre Elias (I)

Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.

Xavier Aldeguer (X)

Digestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain.

Classifications MeSH